BNP Paribas Financial Markets Acquires Shares of 20,367 Inari Medical, Inc. (NASDAQ:NARI)

BNP Paribas Financial Markets purchased a new position in shares of Inari Medical, Inc. (NASDAQ:NARI) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 20,367 shares of the company’s stock, valued at approximately $1,040,000.

A number of other institutional investors and hedge funds have also made changes to their positions in NARI. Adage Capital Partners GP L.L.C. acquired a new position in shares of Inari Medical during the 4th quarter worth $15,139,000. Norges Bank acquired a new position in shares of Inari Medical during the 4th quarter worth $14,447,000. Freshford Capital Management LLC acquired a new position in shares of Inari Medical during the 4th quarter worth $11,057,000. Jennison Associates LLC grew its stake in shares of Inari Medical by 11.8% during the 4th quarter. Jennison Associates LLC now owns 1,763,258 shares of the company’s stock worth $90,014,000 after purchasing an additional 186,617 shares during the period. Finally, Tudor Investment Corp ET AL grew its stake in shares of Inari Medical by 1,327.5% during the 4th quarter. Tudor Investment Corp ET AL now owns 190,405 shares of the company’s stock worth $9,720,000 after purchasing an additional 177,067 shares during the period. 90.98% of the stock is owned by institutional investors and hedge funds.

Inari Medical Price Performance

NASDAQ:NARI opened at $79.97 on Wednesday. Inari Medical, Inc. has a fifty-two week low of $39.76 and a fifty-two week high of $79.99. The stock has a market cap of $4.68 billion, a PE ratio of -59.24 and a beta of 1.02. The firm’s fifty day simple moving average is $79.97 and its 200-day simple moving average is $71.15.

About Inari Medical

Inari Medical, Inc builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States. The company provides ClotTriever system, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases; InThrill system to treat small vessel thrombosis; and LimFlow system for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and risk of major amputation.